Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanofi Director's Dealing 2015

Nov 5, 2015

1643_dirs_2015-11-05_b66d6877-0935-482e-8b7a-a3c61251b53b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MyoKardia Inc (MYOK)
CIK: 0001552451
Period of Report: 2015-11-03

Reporting Person: Sanofi (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-11-03 Common stock Par value per share $ 0.0001 C 2318899 Acquired 2318899 Indirect
2015-11-03 Common stock Par value per share $ 0.0001 P 900000 $10 Acquired 3218899 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-11-03 Series A-1 redeemable convertible preferred stock $0 C 6666667 Disposed Common stocks (1814059) Indirect
2015-11-03 Series B redeemable convertible preferred stock $0 C 1855288 Disposed Common stocks (504840) Indirect

Footnotes

F1: Conversion upon Initial Public Offering